
RTCure
@rtcure_eu
RTCure - Rheuma Tolerance for Cure is an EU/IMI2-funded research project aiming to develop new therapies for rheumatoid arthritis by inducing immune tolerance.
ID: 3059148280
http://www.rtcure.com 24-02-2015 14:52:42
190 Tweet
163 Followers
87 Following


JUST PUBLISHED! A systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations! doi.org/10.1186/s13075… ArthritisResTher

Join our event either virtually or on site in Berlin from May 6-7 and explore the future in Rheumatology! Register today: digitalrheumatology.org/4th-digital-rh… #DigitalRheumatologyDay Latika Johannes Knitza Martin Krusche Thomas Hügle David Simon

At #BSR22 3pm you may like to attend the 'Prediction and prevention of rheumatoid arthritis: an update' session chaired by RACE's Karim Raza with talks from John Isaacs and Marie Falahee amongst others (venue Boisdale) John Isaacs Dr Marie Falahee MRG Newcastle Birmingham Rheumatology Research Group


Want to know more about quantitative preference studies of treatments for #RheumatoidArthritis among #patients and at-risk populations? PREFER: patient preferences published a #SystematicReview! #RA Greiderentusiast R2P2 Inflammation and Ageing 👇 bit.ly/3F3InIC

A landmark paper. RA-MAP Scientific Data - the most complete immunological profile in early rheumatoid arthritis to date RTCure RACE GBN John Isaacs Michael Barnes IMID-Bio-UK nature.com/articles/s4159…

Accelerating diagnosis in #rheumatology using #ehealth📲🚀😀 Great #teamwork Arnd Klyr David Simon led by RachelKnevel supported by EIT Health frontiersin.org/articles/10.33… Digital Rheumatology Network @medizin_digital




JUST PUBLISHED: Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis by G Simons, K Schölin Bywall, M Englbrecht, EC Johansson, RL Disantostefano, C Radawski Jorien Veldwijk K Raza & Dr Marie Falahee 👇 tandfonline.com/doi/full/10.10…



🔔State-of-the-Art Keynote Speaker Meet Dr. John Isaacs, our State-of-the-Art keynote speaker at the 2023 Annual Scientific Meeting! He will be delivering a keynote presentation on Precision Medicine in Rheumatoid Arthritis. Register today🔗asm.rheum.ca



NEW PAPER: What risk of side effects is acceptable for a reduced risk of developing rheumatoid arthritis? Informing patient-focussed drug development rmdopen.bmj.com/cgi/content/fu… PREFER: patient preferences Birmingham Rheumatology Research Group Inflammation and Ageing @NIHRBhamBRC Birmingham Health Partners @unibirm_MDS


